Anti-inflammatory multipurpose female vagina foaming agent

A foam, vaginal technology, used in anti-inflammatory agents, non-central analgesics, sexually transmitted diseases, etc., can solve the problems of delaying the disease, recurrent inflammation, inability to reduce inflammation and sterilization, and achieve the effect of eliminating symptoms and promoting reproduction.

CN111617245APending Publication Date: 2020-09-04福州弘海生物科技有限公司
5 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2020-09-04
Patent Text Reader

Abstract

The invention discloses an anti-inflammatory multipurpose female vaginal foaming agent which comprises chlorhexidine acetate, coconutt diethanol amide, triethanolamine, composite egg yolk antibody, amphotericin B, chitosan, a cordate houttuynia extracting solution, zedoary turmeric oil, a matrine agent and deionized water. The composition comprises composite egg yolk antibody as an active component, and six pathogenic bacteria in the vagina can be killed and the environment in the vagina can be adjusted, so that the pH of the vagina is recovered and kept in a faintly acid state, propagation ofdominant bacteria such as lactic acid bacteria is promoted, and gynecologic inflammatory diseases such as vaginitis and cervicitis are effectively prevented or treatment from the angle of flora adjustment. Various anti-inflammatory and bactericidal drugs are adopted and matched with herba houttuyniae extract and other Chinese herbal medicine lotions to clean, disinfect and sterilize the interiorof the vagina, and flora adjustment is matched for sterilization and disinfection, so that diseases are eliminated in a short time.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention is applied to the field of vaginal anti-inflammation, in particular to a multi-purpose female vaginal foaming agent for anti-inflammation. Background technique

[0002] Gynecological inflammation is a common disease in gynecological clinics. Among them, vaginitis and cervicitis are common gynecological inflammatory diseases. Their onset is mostly related to the imbalance of vaginal microecology in patients, and the treatment effect is poor and the recurrence rate is high. The main pathological change of vaginitis and cervicitis is the imbalance of vaginal flora, that is, the imbalance of microecological flora that normally parasitizes in the vagina, the reduction of beneficial bacteria such as Lactobacillus in the vagina and the proliferation of other bacteria, and the proliferation of anaerobic bacteria at the same time. Amines are produced, which alkalize the vagina, increase vaginal discharge and produce odor. Therefore, the key to pr...

Examples

Embodiment 1

[0023] A multi-purpose female vaginal foam for anti-inflammation, which includes the following components in parts by weight:

[0024] 12 parts of chlorhexidine acetate;

[0025] Coconut oil fatty acid diethanolamide 170 parts;

[0026] 180 parts of triethanolamine;

[0027] Compound egg yolk antibody 15 parts;

[0028] Amphotericin B 6 parts;

[0029] Chitosan 10 parts;

[0030] Houttuynia cordata extract 120 parts;

[0031] 150 parts of zedoary oil;

[0032] 50 parts of matrine agent;

[0033] 3000 parts of deionized water.

[0034] Further, the composite egg yolk antibody is egg yolk antibody powder, and its preparation method is as follows: S1: wash and beat the egg to separate the egg yolk; S2: homogenize and pasteurize; S3: spray dry to obtain Yolk Antibody Powder.

[0035] Further, it also includes the following components by weight: 7 parts of metronidazole; 5 parts of clotrimazole. Metronidazole, clotrimazole, and chlorhexidine acetate foams have the advanta...

Embodiment 2

[0042] The present invention provides an anti-inflammatory multi-purpose vaginal foam for women, which comprises the following components in parts by weight:

[0043] 7.5 parts of chlorhexidine acetate;

[0044] Coconut oil fatty acid diethanolamide 160 parts;

[0045] 100 parts of triethanolamine;

[0046] Compound egg yolk antibody 6.5 parts;

[0047] Amphotericin B 2.4 parts;

[0048] Chitosan 7 parts;

[0049] Houttuynia cordata extract 70 parts;

[0050] Curcuma oil 50 parts;

[0051] 305 parts of matrine agent;

[0052] 500 parts of deionized water.

[0053] Further, the composite egg yolk antibody is egg yolk antibody powder, and its preparation method is as follows: S1: wash and beat the egg to separate the egg yolk; S2: homogenize and pasteurize; S3: spray dry to obtain Yolk Antibody Powder.

[0054] Further, it also includes the following components in parts by weight: 6.5 parts of metronidazole; 4.5 parts of clotrimazole. Metronidazole, clotrimazole, and c...

Embodiment 3

[0059] A multi-purpose female vaginal foam for anti-inflammation, which includes the following components in parts by weight:

[0060] 22.5 parts of chlorhexidine acetate;

[0061] Coconut oil fatty acid diethanolamide 180 parts;

[0062] 250 parts of triethanolamine;

[0063] Compound egg yolk antibody 25 copies;

[0064] Amphotericin B 8.6 parts;

[0065] Chitosan 15 parts;

[0066] Houttuynia cordata extract 200 parts;

[0067] Curcuma oil 200 parts;

[0068] 75 parts of matrine agent;

[0069] 6000 parts of deionized water.

[0070] Further, the composite egg yolk antibody is egg yolk antibody powder, and its preparation method is as follows: S1: wash and beat the egg to separate the egg yolk; S2: homogenize and pasteurize; S3: spray dry to obtain Yolk Antibody Powder.

[0071] Further, it also includes the following components in parts by weight: 8 parts of metronidazole; 6.5 parts of clotrimazole. Metronidazole, clotrimazole, and chlorhexidine acetate foams hav...